nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—Nonsteroidal Anti-inflammatory Compounds—Acetylsalicylic acid—coronary artery disease	0.327	1	CiPCiCtD
Sulindac—AKR1B1—coronary artery disease	0.197	0.89	CbGaD
Sulindac—osteoarthritis—Acetylsalicylic acid—coronary artery disease	0.169	1	CpDpCtD
Sulindac—PTGS2—coronary artery disease	0.013	0.0584	CbGaD
Sulindac—ALB—coronary artery disease	0.0115	0.052	CbGaD
Sulindac—PTGS2—Acetylsalicylic acid—coronary artery disease	0.0111	0.0809	CbGbCtD
Sulindac—SLC22A6—Enalapril—coronary artery disease	0.0108	0.0791	CbGbCtD
Sulindac—ALB—Pitavastatin—coronary artery disease	0.00972	0.071	CbGbCtD
Sulindac—ALB—Valsartan—coronary artery disease	0.00946	0.0691	CbGbCtD
Sulindac—PTGS1—Acetylsalicylic acid—coronary artery disease	0.00935	0.0683	CbGbCtD
Sulindac—SLC22A6—Acetylsalicylic acid—coronary artery disease	0.0082	0.0599	CbGbCtD
Sulindac—SLC22A6—Captopril—coronary artery disease	0.0081	0.0592	CbGbCtD
Sulindac—CYP1A2—Gemfibrozil—coronary artery disease	0.00767	0.0561	CbGbCtD
Sulindac—SLC22A6—Pravastatin—coronary artery disease	0.00765	0.0559	CbGbCtD
Sulindac—ALB—Rosuvastatin—coronary artery disease	0.00717	0.0524	CbGbCtD
Sulindac—ALB—Acetylsalicylic acid—coronary artery disease	0.00698	0.051	CbGbCtD
Sulindac—ALB—Captopril—coronary artery disease	0.0069	0.0504	CbGbCtD
Sulindac—CYP1A2—Clopidogrel—coronary artery disease	0.00665	0.0486	CbGbCtD
Sulindac—SLC22A6—Furosemide—coronary artery disease	0.00651	0.0476	CbGbCtD
Sulindac—SLC22A6—Losartan—coronary artery disease	0.00638	0.0466	CbGbCtD
Sulindac—ALB—Furosemide—coronary artery disease	0.00554	0.0405	CbGbCtD
Sulindac—ALB—Losartan—coronary artery disease	0.00543	0.0397	CbGbCtD
Sulindac—CYP1A2—Losartan—coronary artery disease	0.00325	0.0237	CbGbCtD
Sulindac—MAPK3—artery—coronary artery disease	0.0012	0.0828	CbGeAlD
Sulindac—PTGDR2—heart—coronary artery disease	0.00115	0.0792	CbGeAlD
Sulindac—MAPK3—endothelium—coronary artery disease	0.00101	0.0699	CbGeAlD
Sulindac—AKR1B1—cardiac ventricle—coronary artery disease	0.000928	0.0641	CbGeAlD
Sulindac—AKR1B1—myocardium—coronary artery disease	0.000873	0.0603	CbGeAlD
Sulindac—PTGDR2—blood—coronary artery disease	0.000855	0.0591	CbGeAlD
Sulindac—MAPK3—cardiac ventricle—coronary artery disease	0.000672	0.0464	CbGeAlD
Sulindac—MAPK3—myocardium—coronary artery disease	0.000632	0.0437	CbGeAlD
Sulindac—AKR1B1—heart—coronary artery disease	0.000609	0.0421	CbGeAlD
Sulindac—AKR1B1—cardiovascular system—coronary artery disease	0.000575	0.0397	CbGeAlD
Sulindac—AKR1B1—cardiac atrium—coronary artery disease	0.000521	0.036	CbGeAlD
Sulindac—PPARD—heart—coronary artery disease	0.000479	0.0331	CbGeAlD
Sulindac—AKR1B1—blood—coronary artery disease	0.000454	0.0314	CbGeAlD
Sulindac—MAPK3—heart—coronary artery disease	0.000441	0.0305	CbGeAlD
Sulindac—MAPK3—cardiovascular system—coronary artery disease	0.000417	0.0288	CbGeAlD
Sulindac—MAPK3—cardiac atrium—coronary artery disease	0.000378	0.0261	CbGeAlD
Sulindac—MAPK3—blood—coronary artery disease	0.000329	0.0228	CbGeAlD
Sulindac—PTGS1—artery—coronary artery disease	0.000326	0.0225	CbGeAlD
Sulindac—PTGS2—artery—coronary artery disease	0.000311	0.0215	CbGeAlD
Sulindac—PTGS1—endothelium—coronary artery disease	0.000275	0.019	CbGeAlD
Sulindac—PTGS2—endothelium—coronary artery disease	0.000263	0.0182	CbGeAlD
Sulindac—ALB—heart—coronary artery disease	0.000211	0.0145	CbGeAlD
Sulindac—CYP1A1—cardiac ventricle—coronary artery disease	0.000208	0.0144	CbGeAlD
Sulindac—PTGS1—myocardium—coronary artery disease	0.000172	0.0119	CbGeAlD
Sulindac—CYP1A1—heart—coronary artery disease	0.000137	0.00943	CbGeAlD
Sulindac—PTGS1—heart—coronary artery disease	0.00012	0.00829	CbGeAlD
Sulindac—CYP1A1—cardiac atrium—coronary artery disease	0.000117	0.00807	CbGeAlD
Sulindac—PTGS2—heart—coronary artery disease	0.000115	0.00792	CbGeAlD
Sulindac—PTGS1—cardiovascular system—coronary artery disease	0.000113	0.00782	CbGeAlD
Sulindac—PTGS2—cardiovascular system—coronary artery disease	0.000108	0.00747	CbGeAlD
Sulindac—CYP1A2—blood—coronary artery disease	0.000103	0.00714	CbGeAlD
Sulindac—PTGS1—cardiac atrium—coronary artery disease	0.000103	0.00709	CbGeAlD
Sulindac—CYP1A1—blood—coronary artery disease	0.000102	0.00704	CbGeAlD
Sulindac—PTGS1—blood—coronary artery disease	8.95e-05	0.00618	CbGeAlD
Sulindac—PTGS2—blood—coronary artery disease	8.56e-05	0.00591	CbGeAlD
Sulindac—Asthenia—Olmesartan—coronary artery disease	2.15e-05	0.000308	CcSEcCtD
Sulindac—Headache—Clopidogrel—coronary artery disease	2.15e-05	0.000308	CcSEcCtD
Sulindac—Rash—Lovastatin—coronary artery disease	2.15e-05	0.000308	CcSEcCtD
Sulindac—Dermatitis—Lovastatin—coronary artery disease	2.15e-05	0.000307	CcSEcCtD
Sulindac—Anaemia—Lisinopril—coronary artery disease	2.15e-05	0.000307	CcSEcCtD
Sulindac—Dyspepsia—Losartan—coronary artery disease	2.15e-05	0.000307	CcSEcCtD
Sulindac—Feeling abnormal—Perindopril—coronary artery disease	2.14e-05	0.000306	CcSEcCtD
Sulindac—Headache—Lovastatin—coronary artery disease	2.14e-05	0.000306	CcSEcCtD
Sulindac—Pruritus—Valsartan—coronary artery disease	2.13e-05	0.000305	CcSEcCtD
Sulindac—Chest pain—Timolol—coronary artery disease	2.13e-05	0.000305	CcSEcCtD
Sulindac—Arthralgia—Timolol—coronary artery disease	2.13e-05	0.000305	CcSEcCtD
Sulindac—Myalgia—Timolol—coronary artery disease	2.13e-05	0.000305	CcSEcCtD
Sulindac—Vomiting—Ezetimibe—coronary artery disease	2.13e-05	0.000304	CcSEcCtD
Sulindac—Hypersensitivity—Pravastatin—coronary artery disease	2.13e-05	0.000304	CcSEcCtD
Sulindac—Gastrointestinal pain—Perindopril—coronary artery disease	2.13e-05	0.000304	CcSEcCtD
Sulindac—Angioedema—Lisinopril—coronary artery disease	2.12e-05	0.000303	CcSEcCtD
Sulindac—Pruritus—Olmesartan—coronary artery disease	2.12e-05	0.000303	CcSEcCtD
Sulindac—Decreased appetite—Losartan—coronary artery disease	2.12e-05	0.000303	CcSEcCtD
Sulindac—Body temperature increased—Captopril—coronary artery disease	2.12e-05	0.000302	CcSEcCtD
Sulindac—Dizziness—Simvastatin—coronary artery disease	2.11e-05	0.000302	CcSEcCtD
Sulindac—Rash—Ezetimibe—coronary artery disease	2.11e-05	0.000302	CcSEcCtD
Sulindac—Dermatitis—Ezetimibe—coronary artery disease	2.11e-05	0.000301	CcSEcCtD
Sulindac—Discomfort—Timolol—coronary artery disease	2.11e-05	0.000301	CcSEcCtD
Sulindac—Asthenia—Niacin—coronary artery disease	2.1e-05	0.000301	CcSEcCtD
Sulindac—Fatigue—Losartan—coronary artery disease	2.1e-05	0.0003	CcSEcCtD
Sulindac—Headache—Ezetimibe—coronary artery disease	2.1e-05	0.0003	CcSEcCtD
Sulindac—Malaise—Lisinopril—coronary artery disease	2.1e-05	0.000299	CcSEcCtD
Sulindac—Anaphylactic shock—Ramipril—coronary artery disease	2.09e-05	0.000299	CcSEcCtD
Sulindac—Oedema—Ramipril—coronary artery disease	2.09e-05	0.000299	CcSEcCtD
Sulindac—Vertigo—Lisinopril—coronary artery disease	2.09e-05	0.000298	CcSEcCtD
Sulindac—Constipation—Losartan—coronary artery disease	2.09e-05	0.000298	CcSEcCtD
Sulindac—Syncope—Lisinopril—coronary artery disease	2.08e-05	0.000298	CcSEcCtD
Sulindac—Vomiting—Eplerenone—coronary artery disease	2.08e-05	0.000298	CcSEcCtD
Sulindac—Feeling abnormal—Furosemide—coronary artery disease	2.08e-05	0.000298	CcSEcCtD
Sulindac—Leukopenia—Lisinopril—coronary artery disease	2.08e-05	0.000297	CcSEcCtD
Sulindac—Nausea—Fenofibrate—coronary artery disease	2.08e-05	0.000297	CcSEcCtD
Sulindac—Pruritus—Niacin—coronary artery disease	2.08e-05	0.000296	CcSEcCtD
Sulindac—Asthenia—Pravastatin—coronary artery disease	2.07e-05	0.000296	CcSEcCtD
Sulindac—Gastrointestinal pain—Furosemide—coronary artery disease	2.07e-05	0.000295	CcSEcCtD
Sulindac—Rash—Eplerenone—coronary artery disease	2.07e-05	0.000295	CcSEcCtD
Sulindac—Urticaria—Perindopril—coronary artery disease	2.07e-05	0.000295	CcSEcCtD
Sulindac—Hypersensitivity—Trandolapril—coronary artery disease	2.07e-05	0.000295	CcSEcCtD
Sulindac—Dermatitis—Eplerenone—coronary artery disease	2.07e-05	0.000295	CcSEcCtD
Sulindac—Diarrhoea—Valsartan—coronary artery disease	2.06e-05	0.000295	CcSEcCtD
Sulindac—Shock—Ramipril—coronary artery disease	2.06e-05	0.000294	CcSEcCtD
Sulindac—Hypersensitivity—Enalapril—coronary artery disease	2.06e-05	0.000294	CcSEcCtD
Sulindac—Body temperature increased—Perindopril—coronary artery disease	2.06e-05	0.000294	CcSEcCtD
Sulindac—Palpitations—Lisinopril—coronary artery disease	2.05e-05	0.000293	CcSEcCtD
Sulindac—Diarrhoea—Olmesartan—coronary artery disease	2.05e-05	0.000293	CcSEcCtD
Sulindac—Headache—Eplerenone—coronary artery disease	2.05e-05	0.000293	CcSEcCtD
Sulindac—Thrombocytopenia—Ramipril—coronary artery disease	2.05e-05	0.000293	CcSEcCtD
Sulindac—Anaphylactic shock—Timolol—coronary artery disease	2.05e-05	0.000292	CcSEcCtD
Sulindac—Oedema—Timolol—coronary artery disease	2.05e-05	0.000292	CcSEcCtD
Sulindac—Pruritus—Pravastatin—coronary artery disease	2.04e-05	0.000292	CcSEcCtD
Sulindac—Loss of consciousness—Lisinopril—coronary artery disease	2.04e-05	0.000292	CcSEcCtD
Sulindac—Nausea—Clopidogrel—coronary artery disease	2.04e-05	0.000292	CcSEcCtD
Sulindac—Tachycardia—Ramipril—coronary artery disease	2.04e-05	0.000292	CcSEcCtD
Sulindac—Vomiting—Simvastatin—coronary artery disease	2.03e-05	0.00029	CcSEcCtD
Sulindac—Hypersensitivity—Telmisartan—coronary artery disease	2.03e-05	0.00029	CcSEcCtD
Sulindac—Nausea—Lovastatin—coronary artery disease	2.03e-05	0.00029	CcSEcCtD
Sulindac—Hyperhidrosis—Ramipril—coronary artery disease	2.02e-05	0.000289	CcSEcCtD
Sulindac—Rash—Simvastatin—coronary artery disease	2.01e-05	0.000288	CcSEcCtD
Sulindac—Dermatitis—Simvastatin—coronary artery disease	2.01e-05	0.000287	CcSEcCtD
Sulindac—Asthenia—Trandolapril—coronary artery disease	2.01e-05	0.000287	CcSEcCtD
Sulindac—Shock—Timolol—coronary artery disease	2.01e-05	0.000287	CcSEcCtD
Sulindac—Feeling abnormal—Losartan—coronary artery disease	2.01e-05	0.000287	CcSEcCtD
Sulindac—Urticaria—Furosemide—coronary artery disease	2.01e-05	0.000287	CcSEcCtD
Sulindac—Diarrhoea—Niacin—coronary artery disease	2.01e-05	0.000287	CcSEcCtD
Sulindac—Asthenia—Enalapril—coronary artery disease	2e-05	0.000286	CcSEcCtD
Sulindac—Headache—Simvastatin—coronary artery disease	2e-05	0.000286	CcSEcCtD
Sulindac—Body temperature increased—Furosemide—coronary artery disease	2e-05	0.000286	CcSEcCtD
Sulindac—Gastrointestinal pain—Losartan—coronary artery disease	2e-05	0.000285	CcSEcCtD
Sulindac—Dizziness—Valsartan—coronary artery disease	1.99e-05	0.000285	CcSEcCtD
Sulindac—Anorexia—Ramipril—coronary artery disease	1.99e-05	0.000285	CcSEcCtD
Sulindac—Nausea—Ezetimibe—coronary artery disease	1.99e-05	0.000284	CcSEcCtD
Sulindac—Dizziness—Olmesartan—coronary artery disease	1.99e-05	0.000284	CcSEcCtD
Sulindac—Pruritus—Trandolapril—coronary artery disease	1.98e-05	0.000283	CcSEcCtD
Sulindac—Chest pain—Lisinopril—coronary artery disease	1.98e-05	0.000283	CcSEcCtD
Sulindac—Myalgia—Lisinopril—coronary artery disease	1.98e-05	0.000283	CcSEcCtD
Sulindac—Arthralgia—Lisinopril—coronary artery disease	1.98e-05	0.000283	CcSEcCtD
Sulindac—Hyperhidrosis—Timolol—coronary artery disease	1.98e-05	0.000282	CcSEcCtD
Sulindac—Asthenia—Telmisartan—coronary artery disease	1.98e-05	0.000282	CcSEcCtD
Sulindac—Pruritus—Enalapril—coronary artery disease	1.98e-05	0.000282	CcSEcCtD
Sulindac—Diarrhoea—Pravastatin—coronary artery disease	1.98e-05	0.000282	CcSEcCtD
Sulindac—Discomfort—Lisinopril—coronary artery disease	1.96e-05	0.000279	CcSEcCtD
Sulindac—Hypotension—Ramipril—coronary artery disease	1.95e-05	0.000279	CcSEcCtD
Sulindac—Anorexia—Timolol—coronary artery disease	1.95e-05	0.000278	CcSEcCtD
Sulindac—Pruritus—Telmisartan—coronary artery disease	1.95e-05	0.000278	CcSEcCtD
Sulindac—Nausea—Eplerenone—coronary artery disease	1.95e-05	0.000278	CcSEcCtD
Sulindac—Dizziness—Niacin—coronary artery disease	1.94e-05	0.000277	CcSEcCtD
Sulindac—Urticaria—Losartan—coronary artery disease	1.94e-05	0.000277	CcSEcCtD
Sulindac—Body temperature increased—Losartan—coronary artery disease	1.93e-05	0.000275	CcSEcCtD
Sulindac—Asthenia—Captopril—coronary artery disease	1.92e-05	0.000275	CcSEcCtD
Sulindac—Diarrhoea—Trandolapril—coronary artery disease	1.92e-05	0.000274	CcSEcCtD
Sulindac—Vomiting—Valsartan—coronary artery disease	1.92e-05	0.000274	CcSEcCtD
Sulindac—Diarrhoea—Enalapril—coronary artery disease	1.91e-05	0.000273	CcSEcCtD
Sulindac—Hypotension—Timolol—coronary artery disease	1.91e-05	0.000273	CcSEcCtD
Sulindac—Dizziness—Pravastatin—coronary artery disease	1.91e-05	0.000273	CcSEcCtD
Sulindac—Vomiting—Olmesartan—coronary artery disease	1.91e-05	0.000273	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Ramipril—coronary artery disease	1.91e-05	0.000272	CcSEcCtD
Sulindac—Rash—Valsartan—coronary artery disease	1.9e-05	0.000272	CcSEcCtD
Sulindac—Dermatitis—Valsartan—coronary artery disease	1.9e-05	0.000271	CcSEcCtD
Sulindac—Nausea—Simvastatin—coronary artery disease	1.9e-05	0.000271	CcSEcCtD
Sulindac—Oedema—Lisinopril—coronary artery disease	1.9e-05	0.000271	CcSEcCtD
Sulindac—Anaphylactic shock—Lisinopril—coronary artery disease	1.9e-05	0.000271	CcSEcCtD
Sulindac—Pruritus—Captopril—coronary artery disease	1.9e-05	0.000271	CcSEcCtD
Sulindac—Rash—Olmesartan—coronary artery disease	1.89e-05	0.00027	CcSEcCtD
Sulindac—Insomnia—Ramipril—coronary artery disease	1.89e-05	0.00027	CcSEcCtD
Sulindac—Dermatitis—Olmesartan—coronary artery disease	1.89e-05	0.00027	CcSEcCtD
Sulindac—Headache—Valsartan—coronary artery disease	1.89e-05	0.00027	CcSEcCtD
Sulindac—Diarrhoea—Telmisartan—coronary artery disease	1.89e-05	0.000269	CcSEcCtD
Sulindac—Headache—Olmesartan—coronary artery disease	1.88e-05	0.000269	CcSEcCtD
Sulindac—Paraesthesia—Ramipril—coronary artery disease	1.88e-05	0.000268	CcSEcCtD
Sulindac—Shock—Lisinopril—coronary artery disease	1.87e-05	0.000267	CcSEcCtD
Sulindac—Asthenia—Perindopril—coronary artery disease	1.87e-05	0.000267	CcSEcCtD
Sulindac—Dyspnoea—Ramipril—coronary artery disease	1.87e-05	0.000266	CcSEcCtD
Sulindac—Vomiting—Niacin—coronary artery disease	1.87e-05	0.000266	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Timolol—coronary artery disease	1.86e-05	0.000266	CcSEcCtD
Sulindac—Hypersensitivity—Furosemide—coronary artery disease	1.86e-05	0.000266	CcSEcCtD
Sulindac—Somnolence—Ramipril—coronary artery disease	1.86e-05	0.000266	CcSEcCtD
Sulindac—Thrombocytopenia—Lisinopril—coronary artery disease	1.86e-05	0.000265	CcSEcCtD
Sulindac—Dizziness—Trandolapril—coronary artery disease	1.85e-05	0.000265	CcSEcCtD
Sulindac—Tachycardia—Lisinopril—coronary artery disease	1.85e-05	0.000264	CcSEcCtD
Sulindac—Insomnia—Timolol—coronary artery disease	1.85e-05	0.000264	CcSEcCtD
Sulindac—Rash—Niacin—coronary artery disease	1.85e-05	0.000264	CcSEcCtD
Sulindac—Dermatitis—Niacin—coronary artery disease	1.85e-05	0.000264	CcSEcCtD
Sulindac—Dizziness—Enalapril—coronary artery disease	1.85e-05	0.000264	CcSEcCtD
Sulindac—Dyspepsia—Ramipril—coronary artery disease	1.84e-05	0.000263	CcSEcCtD
Sulindac—Pruritus—Perindopril—coronary artery disease	1.84e-05	0.000263	CcSEcCtD
Sulindac—Headache—Niacin—coronary artery disease	1.84e-05	0.000262	CcSEcCtD
Sulindac—Paraesthesia—Timolol—coronary artery disease	1.84e-05	0.000262	CcSEcCtD
Sulindac—Vomiting—Pravastatin—coronary artery disease	1.84e-05	0.000262	CcSEcCtD
Sulindac—Hyperhidrosis—Lisinopril—coronary artery disease	1.83e-05	0.000262	CcSEcCtD
Sulindac—Diarrhoea—Captopril—coronary artery disease	1.83e-05	0.000262	CcSEcCtD
Sulindac—Dyspnoea—Timolol—coronary artery disease	1.82e-05	0.00026	CcSEcCtD
Sulindac—Dizziness—Telmisartan—coronary artery disease	1.82e-05	0.00026	CcSEcCtD
Sulindac—Rash—Pravastatin—coronary artery disease	1.82e-05	0.00026	CcSEcCtD
Sulindac—Dermatitis—Pravastatin—coronary artery disease	1.82e-05	0.00026	CcSEcCtD
Sulindac—Decreased appetite—Ramipril—coronary artery disease	1.82e-05	0.00026	CcSEcCtD
Sulindac—Somnolence—Timolol—coronary artery disease	1.82e-05	0.00026	CcSEcCtD
Sulindac—Asthenia—Furosemide—coronary artery disease	1.81e-05	0.000259	CcSEcCtD
Sulindac—Headache—Pravastatin—coronary artery disease	1.81e-05	0.000258	CcSEcCtD
Sulindac—Anorexia—Lisinopril—coronary artery disease	1.81e-05	0.000258	CcSEcCtD
Sulindac—Fatigue—Ramipril—coronary artery disease	1.8e-05	0.000258	CcSEcCtD
Sulindac—Dyspepsia—Timolol—coronary artery disease	1.8e-05	0.000257	CcSEcCtD
Sulindac—Hypersensitivity—Losartan—coronary artery disease	1.8e-05	0.000257	CcSEcCtD
Sulindac—Nausea—Valsartan—coronary artery disease	1.79e-05	0.000256	CcSEcCtD
Sulindac—Pruritus—Furosemide—coronary artery disease	1.79e-05	0.000256	CcSEcCtD
Sulindac—Constipation—Ramipril—coronary artery disease	1.79e-05	0.000256	CcSEcCtD
Sulindac—Nausea—Olmesartan—coronary artery disease	1.78e-05	0.000255	CcSEcCtD
Sulindac—Vomiting—Trandolapril—coronary artery disease	1.78e-05	0.000255	CcSEcCtD
Sulindac—Diarrhoea—Perindopril—coronary artery disease	1.78e-05	0.000254	CcSEcCtD
Sulindac—Decreased appetite—Timolol—coronary artery disease	1.78e-05	0.000254	CcSEcCtD
Sulindac—Vomiting—Enalapril—coronary artery disease	1.78e-05	0.000254	CcSEcCtD
Sulindac—Hypotension—Lisinopril—coronary artery disease	1.77e-05	0.000253	CcSEcCtD
Sulindac—Dizziness—Captopril—coronary artery disease	1.77e-05	0.000253	CcSEcCtD
Sulindac—Rash—Trandolapril—coronary artery disease	1.77e-05	0.000253	CcSEcCtD
Sulindac—Dermatitis—Trandolapril—coronary artery disease	1.77e-05	0.000252	CcSEcCtD
Sulindac—Fatigue—Timolol—coronary artery disease	1.76e-05	0.000252	CcSEcCtD
Sulindac—Rash—Enalapril—coronary artery disease	1.76e-05	0.000252	CcSEcCtD
Sulindac—Dermatitis—Enalapril—coronary artery disease	1.76e-05	0.000251	CcSEcCtD
Sulindac—Headache—Trandolapril—coronary artery disease	1.76e-05	0.000251	CcSEcCtD
Sulindac—Vomiting—Telmisartan—coronary artery disease	1.75e-05	0.00025	CcSEcCtD
Sulindac—Asthenia—Losartan—coronary artery disease	1.75e-05	0.00025	CcSEcCtD
Sulindac—Headache—Enalapril—coronary artery disease	1.75e-05	0.00025	CcSEcCtD
Sulindac—Nausea—Niacin—coronary artery disease	1.74e-05	0.000249	CcSEcCtD
Sulindac—Rash—Telmisartan—coronary artery disease	1.74e-05	0.000248	CcSEcCtD
Sulindac—Dermatitis—Telmisartan—coronary artery disease	1.74e-05	0.000248	CcSEcCtD
Sulindac—Diarrhoea—Furosemide—coronary artery disease	1.73e-05	0.000247	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Lisinopril—coronary artery disease	1.73e-05	0.000247	CcSEcCtD
Sulindac—Pruritus—Losartan—coronary artery disease	1.73e-05	0.000247	CcSEcCtD
Sulindac—Headache—Telmisartan—coronary artery disease	1.73e-05	0.000247	CcSEcCtD
Sulindac—Feeling abnormal—Ramipril—coronary artery disease	1.72e-05	0.000246	CcSEcCtD
Sulindac—Dizziness—Perindopril—coronary artery disease	1.72e-05	0.000246	CcSEcCtD
Sulindac—Insomnia—Lisinopril—coronary artery disease	1.72e-05	0.000245	CcSEcCtD
Sulindac—Nausea—Pravastatin—coronary artery disease	1.72e-05	0.000245	CcSEcCtD
Sulindac—Gastrointestinal pain—Ramipril—coronary artery disease	1.71e-05	0.000244	CcSEcCtD
Sulindac—Paraesthesia—Lisinopril—coronary artery disease	1.7e-05	0.000243	CcSEcCtD
Sulindac—Vomiting—Captopril—coronary artery disease	1.7e-05	0.000243	CcSEcCtD
Sulindac—Dyspnoea—Lisinopril—coronary artery disease	1.69e-05	0.000242	CcSEcCtD
Sulindac—Rash—Captopril—coronary artery disease	1.69e-05	0.000241	CcSEcCtD
Sulindac—Dermatitis—Captopril—coronary artery disease	1.69e-05	0.000241	CcSEcCtD
Sulindac—Somnolence—Lisinopril—coronary artery disease	1.69e-05	0.000241	CcSEcCtD
Sulindac—Feeling abnormal—Timolol—coronary artery disease	1.69e-05	0.000241	CcSEcCtD
Sulindac—Headache—Captopril—coronary artery disease	1.68e-05	0.00024	CcSEcCtD
Sulindac—Gastrointestinal pain—Timolol—coronary artery disease	1.67e-05	0.000239	CcSEcCtD
Sulindac—Dizziness—Furosemide—coronary artery disease	1.67e-05	0.000239	CcSEcCtD
Sulindac—Dyspepsia—Lisinopril—coronary artery disease	1.67e-05	0.000239	CcSEcCtD
Sulindac—Diarrhoea—Losartan—coronary artery disease	1.67e-05	0.000238	CcSEcCtD
Sulindac—Nausea—Trandolapril—coronary artery disease	1.67e-05	0.000238	CcSEcCtD
Sulindac—Urticaria—Ramipril—coronary artery disease	1.66e-05	0.000237	CcSEcCtD
Sulindac—Nausea—Enalapril—coronary artery disease	1.66e-05	0.000237	CcSEcCtD
Sulindac—Vomiting—Perindopril—coronary artery disease	1.65e-05	0.000236	CcSEcCtD
Sulindac—Body temperature increased—Ramipril—coronary artery disease	1.65e-05	0.000236	CcSEcCtD
Sulindac—Decreased appetite—Lisinopril—coronary artery disease	1.65e-05	0.000236	CcSEcCtD
Sulindac—Rash—Perindopril—coronary artery disease	1.64e-05	0.000234	CcSEcCtD
Sulindac—Dermatitis—Perindopril—coronary artery disease	1.64e-05	0.000234	CcSEcCtD
Sulindac—Nausea—Telmisartan—coronary artery disease	1.64e-05	0.000234	CcSEcCtD
Sulindac—Fatigue—Lisinopril—coronary artery disease	1.64e-05	0.000234	CcSEcCtD
Sulindac—Headache—Perindopril—coronary artery disease	1.63e-05	0.000233	CcSEcCtD
Sulindac—Urticaria—Timolol—coronary artery disease	1.62e-05	0.000232	CcSEcCtD
Sulindac—Constipation—Lisinopril—coronary artery disease	1.62e-05	0.000232	CcSEcCtD
Sulindac—Body temperature increased—Timolol—coronary artery disease	1.62e-05	0.000231	CcSEcCtD
Sulindac—Dizziness—Losartan—coronary artery disease	1.61e-05	0.00023	CcSEcCtD
Sulindac—Vomiting—Furosemide—coronary artery disease	1.61e-05	0.00023	CcSEcCtD
Sulindac—Rash—Furosemide—coronary artery disease	1.59e-05	0.000228	CcSEcCtD
Sulindac—Dermatitis—Furosemide—coronary artery disease	1.59e-05	0.000228	CcSEcCtD
Sulindac—Nausea—Captopril—coronary artery disease	1.59e-05	0.000227	CcSEcCtD
Sulindac—Headache—Furosemide—coronary artery disease	1.58e-05	0.000226	CcSEcCtD
Sulindac—Feeling abnormal—Lisinopril—coronary artery disease	1.56e-05	0.000223	CcSEcCtD
Sulindac—Gastrointestinal pain—Lisinopril—coronary artery disease	1.55e-05	0.000222	CcSEcCtD
Sulindac—Vomiting—Losartan—coronary artery disease	1.55e-05	0.000222	CcSEcCtD
Sulindac—Nausea—Perindopril—coronary artery disease	1.55e-05	0.000221	CcSEcCtD
Sulindac—Hypersensitivity—Ramipril—coronary artery disease	1.54e-05	0.00022	CcSEcCtD
Sulindac—Rash—Losartan—coronary artery disease	1.54e-05	0.00022	CcSEcCtD
Sulindac—Dermatitis—Losartan—coronary artery disease	1.54e-05	0.00022	CcSEcCtD
Sulindac—Headache—Losartan—coronary artery disease	1.53e-05	0.000218	CcSEcCtD
Sulindac—Urticaria—Lisinopril—coronary artery disease	1.51e-05	0.000215	CcSEcCtD
Sulindac—Hypersensitivity—Timolol—coronary artery disease	1.51e-05	0.000215	CcSEcCtD
Sulindac—Nausea—Furosemide—coronary artery disease	1.5e-05	0.000215	CcSEcCtD
Sulindac—Asthenia—Ramipril—coronary artery disease	1.5e-05	0.000214	CcSEcCtD
Sulindac—Body temperature increased—Lisinopril—coronary artery disease	1.5e-05	0.000214	CcSEcCtD
Sulindac—Pruritus—Ramipril—coronary artery disease	1.48e-05	0.000211	CcSEcCtD
Sulindac—Asthenia—Timolol—coronary artery disease	1.47e-05	0.00021	CcSEcCtD
Sulindac—Nausea—Losartan—coronary artery disease	1.45e-05	0.000207	CcSEcCtD
Sulindac—Pruritus—Timolol—coronary artery disease	1.45e-05	0.000207	CcSEcCtD
Sulindac—Diarrhoea—Ramipril—coronary artery disease	1.43e-05	0.000204	CcSEcCtD
Sulindac—Diarrhoea—Timolol—coronary artery disease	1.4e-05	0.0002	CcSEcCtD
Sulindac—Hypersensitivity—Lisinopril—coronary artery disease	1.4e-05	0.0002	CcSEcCtD
Sulindac—Dizziness—Ramipril—coronary artery disease	1.38e-05	0.000198	CcSEcCtD
Sulindac—Asthenia—Lisinopril—coronary artery disease	1.36e-05	0.000194	CcSEcCtD
Sulindac—Dizziness—Timolol—coronary artery disease	1.35e-05	0.000193	CcSEcCtD
Sulindac—Pruritus—Lisinopril—coronary artery disease	1.34e-05	0.000192	CcSEcCtD
Sulindac—Vomiting—Ramipril—coronary artery disease	1.33e-05	0.00019	CcSEcCtD
Sulindac—Rash—Ramipril—coronary artery disease	1.32e-05	0.000188	CcSEcCtD
Sulindac—Dermatitis—Ramipril—coronary artery disease	1.32e-05	0.000188	CcSEcCtD
Sulindac—Headache—Ramipril—coronary artery disease	1.31e-05	0.000187	CcSEcCtD
Sulindac—Vomiting—Timolol—coronary artery disease	1.3e-05	0.000186	CcSEcCtD
Sulindac—Diarrhoea—Lisinopril—coronary artery disease	1.3e-05	0.000185	CcSEcCtD
Sulindac—Rash—Timolol—coronary artery disease	1.29e-05	0.000184	CcSEcCtD
Sulindac—Dermatitis—Timolol—coronary artery disease	1.29e-05	0.000184	CcSEcCtD
Sulindac—Headache—Timolol—coronary artery disease	1.28e-05	0.000183	CcSEcCtD
Sulindac—Dizziness—Lisinopril—coronary artery disease	1.25e-05	0.000179	CcSEcCtD
Sulindac—Nausea—Ramipril—coronary artery disease	1.24e-05	0.000177	CcSEcCtD
Sulindac—Nausea—Timolol—coronary artery disease	1.21e-05	0.000174	CcSEcCtD
Sulindac—Vomiting—Lisinopril—coronary artery disease	1.21e-05	0.000172	CcSEcCtD
Sulindac—Rash—Lisinopril—coronary artery disease	1.2e-05	0.000171	CcSEcCtD
Sulindac—Dermatitis—Lisinopril—coronary artery disease	1.2e-05	0.000171	CcSEcCtD
Sulindac—Headache—Lisinopril—coronary artery disease	1.19e-05	0.00017	CcSEcCtD
Sulindac—Nausea—Lisinopril—coronary artery disease	1.13e-05	0.000161	CcSEcCtD
Sulindac—PTGS2—Metabolism—GGT1—coronary artery disease	8.98e-07	1.48e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GPX1—coronary artery disease	8.94e-07	1.47e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—JAK2—coronary artery disease	8.92e-07	1.47e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GPX2—coronary artery disease	8.91e-07	1.47e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOA2—coronary artery disease	8.91e-07	1.47e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PLA2G2A—coronary artery disease	8.91e-07	1.47e-05	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—AKT1—coronary artery disease	8.9e-07	1.46e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—AKT1—coronary artery disease	8.88e-07	1.46e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—JAK2—coronary artery disease	8.86e-07	1.46e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ABCG5—coronary artery disease	8.8e-07	1.45e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SULT1A1—coronary artery disease	8.8e-07	1.45e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GPX4—coronary artery disease	8.8e-07	1.45e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—HK1—coronary artery disease	8.8e-07	1.45e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HIF1A—coronary artery disease	8.79e-07	1.45e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	8.79e-07	1.45e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—AGT—coronary artery disease	8.75e-07	1.44e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—FGF1—coronary artery disease	8.75e-07	1.44e-05	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—AKT1—coronary artery disease	8.71e-07	1.43e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CD36—coronary artery disease	8.71e-07	1.43e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PSMB5—coronary artery disease	8.7e-07	1.43e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PSMA6—coronary artery disease	8.7e-07	1.43e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—HADHA—coronary artery disease	8.69e-07	1.43e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—LPL—coronary artery disease	8.69e-07	1.43e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PPP2CA—coronary artery disease	8.6e-07	1.42e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GSTA1—coronary artery disease	8.59e-07	1.41e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—LEP—coronary artery disease	8.58e-07	1.41e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—APOE—coronary artery disease	8.58e-07	1.41e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—IL6—coronary artery disease	8.5e-07	1.4e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—LPA—coronary artery disease	8.5e-07	1.4e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CTGF—coronary artery disease	8.5e-07	1.4e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PLCB1—coronary artery disease	8.49e-07	1.4e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—APOA1—coronary artery disease	8.48e-07	1.4e-05	CbGpPWpGaD
Sulindac—PPARD—Metabolism—PIK3CA—coronary artery disease	8.47e-07	1.39e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL1B—coronary artery disease	8.46e-07	1.39e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GOT2—coronary artery disease	8.42e-07	1.39e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—HMGCR—coronary artery disease	8.42e-07	1.39e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—KDR—coronary artery disease	8.4e-07	1.38e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—PTGS2—coronary artery disease	8.39e-07	1.38e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MAPK14—coronary artery disease	8.35e-07	1.37e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	8.33e-07	1.37e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—MTHFR—coronary artery disease	8.25e-07	1.36e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ABCA1—coronary artery disease	8.23e-07	1.35e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PLCB3—coronary artery disease	8.23e-07	1.35e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ESR1—coronary artery disease	8.19e-07	1.35e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—PPP2CA—coronary artery disease	8.15e-07	1.34e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOA5—coronary artery disease	8.15e-07	1.34e-05	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—AKT1—coronary artery disease	8.13e-07	1.34e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FN1—coronary artery disease	8.09e-07	1.33e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—F2—coronary artery disease	8.09e-07	1.33e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GSTP1—coronary artery disease	8.07e-07	1.33e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL6ST—coronary artery disease	8.06e-07	1.33e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—PRKCD—coronary artery disease	8.01e-07	1.32e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PPARGC1A—coronary artery disease	7.99e-07	1.32e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NFKBIA—coronary artery disease	7.99e-07	1.32e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—P4HB—coronary artery disease	7.99e-07	1.31e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GGT1—coronary artery disease	7.97e-07	1.31e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GOT1—coronary artery disease	7.97e-07	1.31e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—HMOX1—coronary artery disease	7.96e-07	1.31e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	7.91e-07	1.3e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CAT—coronary artery disease	7.85e-07	1.29e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—AKT1—coronary artery disease	7.84e-07	1.29e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—AGT—coronary artery disease	7.84e-07	1.29e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	7.84e-07	1.29e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—MTHFR—coronary artery disease	7.82e-07	1.29e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	7.75e-07	1.28e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PLCB1—coronary artery disease	7.74e-07	1.27e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—KIT—coronary artery disease	7.74e-07	1.27e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—APOE—coronary artery disease	7.69e-07	1.26e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	7.66e-07	1.26e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—APOB—coronary artery disease	7.62e-07	1.25e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—APOA1—coronary artery disease	7.6e-07	1.25e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	7.59e-07	1.25e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—ABCA1—coronary artery disease	7.5e-07	1.24e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—HIF1A—coronary artery disease	7.46e-07	1.23e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—GSK3B—coronary artery disease	7.43e-07	1.22e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GSTM1—coronary artery disease	7.41e-07	1.22e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—VCAN—coronary artery disease	7.39e-07	1.22e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—POMC—coronary artery disease	7.37e-07	1.21e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CREB1—coronary artery disease	7.37e-07	1.21e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ALDOA—coronary artery disease	7.33e-07	1.21e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—APOE—coronary artery disease	7.28e-07	1.2e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—LPL—coronary artery disease	7.28e-07	1.2e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	7.27e-07	1.2e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GOT1—coronary artery disease	7.27e-07	1.2e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GGT1—coronary artery disease	7.27e-07	1.2e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCL2—coronary artery disease	7.21e-07	1.19e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—APOA1—coronary artery disease	7.2e-07	1.19e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL6R—coronary artery disease	7.19e-07	1.18e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GSTP1—coronary artery disease	7.16e-07	1.18e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—DCN—coronary artery disease	7.12e-07	1.17e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GPX1—coronary artery disease	7.1e-07	1.17e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PPARGC1A—coronary artery disease	7.09e-07	1.17e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IGF1—coronary artery disease	7.09e-07	1.17e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—HMOX1—coronary artery disease	7.06e-07	1.16e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—MAPK1—coronary artery disease	7.05e-07	1.16e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CAT—coronary artery disease	6.97e-07	1.15e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ALDH2—coronary artery disease	6.93e-07	1.14e-05	CbGpPWpGaD
Sulindac—PPARD—Metabolism—AKT1—coronary artery disease	6.92e-07	1.14e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CD36—coronary artery disease	6.92e-07	1.14e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IL6ST—coronary artery disease	6.84e-07	1.13e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PPP2CA—coronary artery disease	6.83e-07	1.12e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOS2—coronary artery disease	6.79e-07	1.12e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—APOB—coronary artery disease	6.77e-07	1.11e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	6.75e-07	1.11e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—HBA1—coronary artery disease	6.75e-07	1.11e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—LIPC—coronary artery disease	6.75e-07	1.11e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CYP2C19—coronary artery disease	6.75e-07	1.11e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	6.75e-07	1.11e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SERPINE1—coronary artery disease	6.73e-07	1.11e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOC3—coronary artery disease	6.71e-07	1.1e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PPARG—coronary artery disease	6.69e-07	1.1e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—LDLR—coronary artery disease	6.67e-07	1.1e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	6.66e-07	1.1e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—POMC—coronary artery disease	6.6e-07	1.09e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SLC9A1—coronary artery disease	6.59e-07	1.08e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GSTT1—coronary artery disease	6.59e-07	1.08e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GSTM1—coronary artery disease	6.58e-07	1.08e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—KIT—coronary artery disease	6.57e-07	1.08e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—VEGFA—coronary artery disease	6.57e-07	1.08e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—MTHFR—coronary artery disease	6.55e-07	1.08e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GSTP1—coronary artery disease	6.53e-07	1.07e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FGF2—coronary artery disease	6.52e-07	1.07e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CETP—coronary artery disease	6.51e-07	1.07e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GCLC—coronary artery disease	6.51e-07	1.07e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PPARGC1A—coronary artery disease	6.47e-07	1.06e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—LPL—coronary artery disease	6.46e-07	1.06e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—MAPK1—coronary artery disease	6.45e-07	1.06e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SDC1—coronary artery disease	6.44e-07	1.06e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—HMOX1—coronary artery disease	6.44e-07	1.06e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NOS3—coronary artery disease	6.43e-07	1.06e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CAT—coronary artery disease	6.35e-07	1.05e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—GSK3B—coronary artery disease	6.31e-07	1.04e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GPX1—coronary artery disease	6.3e-07	1.04e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CREB1—coronary artery disease	6.26e-07	1.03e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—JAK2—coronary artery disease	6.25e-07	1.03e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—AGT—coronary artery disease	6.23e-07	1.02e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—APOB—coronary artery disease	6.17e-07	1.02e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CD36—coronary artery disease	6.14e-07	1.01e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—PIK3CA—coronary artery disease	6.12e-07	1.01e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IL6R—coronary artery disease	6.1e-07	1e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—APOE—coronary artery disease	6.1e-07	1e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PSMA6—coronary artery disease	6.08e-07	1e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PSMB5—coronary artery disease	6.08e-07	1e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	6.07e-07	9.99e-06	CbGpPWpGaD
Sulindac—MAPK3—Disease—TGFB1—coronary artery disease	6.07e-07	9.99e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PPP2CA—coronary artery disease	6.06e-07	9.98e-06	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—APOA1—coronary artery disease	6.03e-07	9.93e-06	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TGFB1—coronary artery disease	6.03e-07	9.93e-06	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ALB—coronary artery disease	6.02e-07	9.91e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—GSTM1—coronary artery disease	6e-07	9.87e-06	CbGpPWpGaD
Sulindac—MAPK3—Disease—MAPK1—coronary artery disease	5.95e-07	9.8e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CTGF—coronary artery disease	5.94e-07	9.78e-06	CbGpPWpGaD
Sulindac—ALB—Hemostasis—MAPK1—coronary artery disease	5.91e-07	9.73e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—HMGCR—coronary artery disease	5.89e-07	9.69e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GOT2—coronary artery disease	5.89e-07	9.69e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—LPL—coronary artery disease	5.89e-07	9.69e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—MTHFR—coronary artery disease	5.82e-07	9.57e-06	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	5.77e-07	9.51e-06	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—NOS3—coronary artery disease	5.76e-07	9.48e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—GPX1—coronary artery disease	5.74e-07	9.46e-06	CbGpPWpGaD
Sulindac—PTGS2—Disease—SERPINE1—coronary artery disease	5.72e-07	9.41e-06	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CXCL8—coronary artery disease	5.7e-07	9.38e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—CD36—coronary artery disease	5.59e-07	9.21e-06	CbGpPWpGaD
Sulindac—MAPK3—Immune System—PIK3CA—coronary artery disease	5.59e-07	9.21e-06	CbGpPWpGaD
Sulindac—PTGS2—Disease—FGF2—coronary artery disease	5.53e-07	9.11e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—AGT—coronary artery disease	5.53e-07	9.1e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—PPP2CA—coronary artery disease	5.52e-07	9.09e-06	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOS3—coronary artery disease	5.46e-07	8.98e-06	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CASP3—coronary artery disease	5.46e-07	8.98e-06	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL6—coronary artery disease	5.42e-07	8.92e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PLCB1—coronary artery disease	5.42e-07	8.91e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—APOE—coronary artery disease	5.41e-07	8.91e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—APOA1—coronary artery disease	5.35e-07	8.81e-06	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PPARG—coronary artery disease	5.31e-07	8.75e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	5.31e-07	8.74e-06	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCND1—coronary artery disease	5.31e-07	8.74e-06	CbGpPWpGaD
Sulindac—PTGS2—Disease—JAK2—coronary artery disease	5.3e-07	8.73e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—MTHFR—coronary artery disease	5.3e-07	8.73e-06	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PTGS2—coronary artery disease	5.27e-07	8.67e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ABCA1—coronary artery disease	5.25e-07	8.64e-06	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—POMC—coronary artery disease	5.24e-07	8.63e-06	CbGpPWpGaD
Sulindac—MAPK3—Disease—PIK3CA—coronary artery disease	5.16e-07	8.5e-06	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MMP9—coronary artery disease	5.16e-07	8.49e-06	CbGpPWpGaD
Sulindac—ALB—Hemostasis—PIK3CA—coronary artery disease	5.13e-07	8.45e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	5.13e-07	8.44e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GOT1—coronary artery disease	5.08e-07	8.37e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GGT1—coronary artery disease	5.08e-07	8.37e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—AGT—coronary artery disease	5.04e-07	8.29e-06	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—AKT1—coronary artery disease	5e-07	8.23e-06	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL6—coronary artery disease	4.95e-07	8.15e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—APOE—coronary artery disease	4.94e-07	8.12e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—APOA1—coronary artery disease	4.88e-07	8.03e-06	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ALB—coronary artery disease	4.78e-07	7.86e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PPARG—coronary artery disease	4.72e-07	7.76e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.67e-07	7.69e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—POMC—coronary artery disease	4.65e-07	7.66e-06	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—VEGFA—coronary artery disease	4.63e-07	7.62e-06	CbGpPWpGaD
Sulindac—MAPK3—Disease—IL6—coronary artery disease	4.57e-07	7.53e-06	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—NOS3—coronary artery disease	4.57e-07	7.52e-06	CbGpPWpGaD
Sulindac—MAPK3—Immune System—AKT1—coronary artery disease	4.57e-07	7.52e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GSTP1—coronary artery disease	4.57e-07	7.52e-06	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—AKT1—coronary artery disease	4.54e-07	7.48e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	4.52e-07	7.45e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—HMOX1—coronary artery disease	4.5e-07	7.41e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CAT—coronary artery disease	4.44e-07	7.31e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOB—coronary artery disease	4.31e-07	7.1e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—PPARG—coronary artery disease	4.3e-07	7.08e-06	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TGFB1—coronary artery disease	4.25e-07	6.99e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ALB—coronary artery disease	4.24e-07	6.98e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—POMC—coronary artery disease	4.24e-07	6.98e-06	CbGpPWpGaD
Sulindac—MAPK3—Disease—AKT1—coronary artery disease	4.22e-07	6.94e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GSTM1—coronary artery disease	4.2e-07	6.91e-06	CbGpPWpGaD
Sulindac—ALB—Hemostasis—AKT1—coronary artery disease	4.19e-07	6.9e-06	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MAPK1—coronary artery disease	4.17e-07	6.86e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—LPL—coronary artery disease	4.12e-07	6.78e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—NOS3—coronary artery disease	4.06e-07	6.68e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GPX1—coronary artery disease	4.02e-07	6.61e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CD36—coronary artery disease	3.91e-07	6.44e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PPP2CA—coronary artery disease	3.86e-07	6.36e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PTGS2—coronary artery disease	3.71e-07	6.11e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—MTHFR—coronary artery disease	3.71e-07	6.1e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—NOS3—coronary artery disease	3.7e-07	6.09e-06	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PIK3CA—coronary artery disease	3.62e-07	5.95e-06	CbGpPWpGaD
Sulindac—PTGS2—Disease—TGFB1—coronary artery disease	3.61e-07	5.94e-06	CbGpPWpGaD
Sulindac—PTGS2—Disease—MAPK1—coronary artery disease	3.54e-07	5.83e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—AGT—coronary artery disease	3.52e-07	5.8e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOE—coronary artery disease	3.45e-07	5.68e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOA1—coronary artery disease	3.41e-07	5.62e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—PTGS2—coronary artery disease	3.38e-07	5.57e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.27e-07	5.38e-06	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PIK3CA—coronary artery disease	3.24e-07	5.33e-06	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL6—coronary artery disease	3.2e-07	5.27e-06	CbGpPWpGaD
Sulindac—PTGS2—Disease—PIK3CA—coronary artery disease	3.07e-07	5.05e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PPARG—coronary artery disease	3.01e-07	4.95e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—POMC—coronary artery disease	2.97e-07	4.88e-06	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—AKT1—coronary artery disease	2.95e-07	4.86e-06	CbGpPWpGaD
Sulindac—PTGS2—Disease—IL6—coronary artery disease	2.72e-07	4.48e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ALB—coronary artery disease	2.7e-07	4.45e-06	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—AKT1—coronary artery disease	2.65e-07	4.36e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NOS3—coronary artery disease	2.59e-07	4.26e-06	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PIK3CA—coronary artery disease	2.57e-07	4.23e-06	CbGpPWpGaD
Sulindac—PTGS2—Disease—AKT1—coronary artery disease	2.51e-07	4.13e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PTGS2—coronary artery disease	2.37e-07	3.89e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PIK3CA—coronary artery disease	2.28e-07	3.76e-06	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—AKT1—coronary artery disease	2.1e-07	3.46e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—PIK3CA—coronary artery disease	2.08e-07	3.42e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—AKT1—coronary artery disease	1.86e-07	3.07e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—AKT1—coronary artery disease	1.7e-07	2.8e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PIK3CA—coronary artery disease	1.46e-07	2.4e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—AKT1—coronary artery disease	1.19e-07	1.96e-06	CbGpPWpGaD
